The photo has been used for illustrative purposes.
Certain class of cancer drugs could be used in the future to treat chronic obstructive pulmonary disease (COPD), say researchers, adding that the drugs could be developed to stop the progression of the disease and promote healing within the lungs.
COPD makes breathing progressively more difficult for millions of people around the world, and the study, published in the journal eLIFE has shown the potential for clinically available cancer treatments to treat it.
"COPD is usually treated with steroids and airway muscle relaxants which ease symptoms, but there is currently no effective treatment clinically available to counteract the damage it does to the lungs," said study researcher Lynne Prince from the University of Sheffield in UK.
"Our research now shows that inhibitors of these cell signalling processes, or ErbB kinases, could have therapeutic potential in neutrophilic inflammatory disease," Prince added.
Accroding to the researchers, the hope of these drugs is that they can clear the damaging cells from the lungs of people living with COPD, preventing any further damage and therefore the progression of the disease for the first time.
They have been investigating the effect of drugs used to treat a variety of cancers on this inflammatory response; the main driver of lung damage in people living with COPD.
People living with COPD experience a wide range of symptoms that have an increasing impact on their quality of life, including breathlessness, coughing and frequent chest infections.
The damage to the lungs is driven by inflammation caused by immune cells called neutrophils.
For the results, the research team screened a library of cancer drugs and identified a number of compounds which accelerate the death of the neutrophil cells and promote healing in the lungs.
The research discovered that specific cancer drugs inhibit a cell signalling process controlling the death-rate of the harmful neutrophils.
The team also discovered that editing the genes that encode the cell signalling in the first place, further decreased inflammation.
"As neutrophilic inflammation is also central to the progression of other chronic inflammatory diseases such as rheumatoid arthritis, the research has the potential to impact not only people living with COPD," said study researcher Stephen Renshaw from the University of Sheffield in UK.
"Our next step is to find a way to test these drugs in people with COPD to understand how the ErbB kinase signalling process has an effect on lung inflammation and to address any potential side effects," Renshaw added.
Excess of sugary drinks such as soda and fruit juice is linked to a higher risk of developing certain kinds of cancer, researchers reported on Thursday.
While advanced medical treatments can help patients with breast cancer survive the disease, some options could make them more prone to several other health issues, according to a new report.
Cancer has become the leading cause of death in rich nations, overtaking heart disease, according to the results of two landmark, decade-long global surveys of health trends released on Tuesday.
When Belgium's coronavirus lockdown order forced star chef Isabelle Arpin to shut her fine dining establishment she could have retired to the kitchen to devise dishes for bored gourmets.
Costa Rican Flower farmers have started destroying lilies, roses and chrysanthemums after the coronavirus outbreak led to the suspension of flights to markets in the United States and Canada.
In an empty park overshadowed by Hong Kong's cramped apartment blocks, personal trainer Kristen Handford presses record on her phone and begins a workout for clients trying to stay fit at home.